Boehringer will gain access to the de-identified database of Tempus, which comprises clinical, imaging and molecular data.

AZ and Qure.ai have been working together since 2022, through the pharma group's Emerging Markets Health Innovation Hubs programme. Lung cancer is the UK's biggest cancer killer, with around ...

AstraZeneca has enlisted the help of Lilly in the development of its new Alzheimer's candidate AZD3293. The drug is an oral beta secretase cleaving enzyme (BACE) inhibitor, which the companies ...

June 4 to 5, 2025 AI & Big Data Expo North America 2025 Santa Clara, CA June 4 to 5, 2025 TechEx North America Santa Clara, CA June 4 to 5, 2025 Digital Transformation Week Expo North America Santa ...